QA: Kalvista Pharmaceuticals Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001348911_2019_Kalvista_Pharmaceuticals_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001348911, Kalvista Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 59,380,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,836,000
3 remainder_Assets 173,000
4 LiabilitiesCurrent 23,216,000
5 LiabilitiesNoncurrent 10,920,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 9,641,760
9 ResearchAndDevelopmentExpense 17,628,415
10 remainder_Expenses 0
11 remainder_Revenues 42,832,700
12 remainder_NetIncome 3,184,569
13 remainder_ComprehensiveNetIncome 1,097,226
  yvar yval
0 Assets 61,389,000
1 Liabilities 34,136,000
2 Expenses 27,270,175
3 Revenues 42,832,700
4 StockholdersEquity 27,253,000
5 NetIncome 18,747,094
6 ComprehensiveNetIncome 19,295,707
7 BaseVar 84,954,835
8 EconomicCapitalRatiobeforeLimitedLiability 1.65
9 EconomicCapitalRatio 2.78

Edgar->Model Mapping

Feature Distribution

Change over Time